Literature DB >> 890413

A case of Ebola virus infection.

R T Emond, B Evans, E T Bowen, G Lloyd.   

Abstract

In November 1976 an investigator at the Microbiological Research Establishment accidentally inoculated himself while processing material from patients in Africa who had been suffering from a haemorrhagic fever of unknown cause. He developed an illness closely resembling Marburg disease, and a virus was isolated from his blood that resembled Marburg virus but was distinct serologically. The course of the illness was mild and may have been modified by treatment with human interferon and convalescent serum. Convalescence was protracted; there was evidence of bone-marrow depression and virus was excreted in low titre for some weeks. Recovery was complete. Infection was contained by barrier-nursing techniques using a negative-pressure plastic isolator and infection did not spread to attendant staff or to the community.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 890413      PMCID: PMC1631428          DOI: 10.1136/bmj.2.6086.541

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  Inhibition of the primary in vitro antibody response by interferon preparations.

Authors:  H M Johnson; B G Smith; S Baron
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

2.  Isolation for high-risk patients.

Authors:  R T Emond
Journal:  Postgrad Med J       Date:  1976-09       Impact factor: 2.401

3.  Correlation between the antiviral effect of interferon treatment and the inhibition of in vitro mRNA translation in noninfected L cells.

Authors:  E Falcoff; R Falcoff; B Lebleu; M Revel
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

4.  Inhibition of haemopoietic colony growth by interferon preparations from different sources.

Authors:  T A McNeill; I Gresser
Journal:  Nat New Biol       Date:  1973-08-08

5.  The effects of an inhibiting factor (interferon) on the in vitro growth of granulocyte-macrophage colonies.

Authors:  W A Fleming; T A McNeill; M Killen
Journal:  Immunology       Date:  1972-09       Impact factor: 7.397

6.  Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire.

Authors:  K M Johnson; J V Lange; P A Webb; F A Murphy
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

7.  [Toxicity of human leucocyte interferon preparations in human bone-marrow cultures].

Authors:  C Nissen; B Speck; G Emödi; N N Iscove
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

8.  Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent.

Authors:  E T Bowen; G Lloyd; W J Harris; G S Platt; A Baskerville; E E Vella
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

9.  Marburg virus disease.

Authors:  G A Martini
Journal:  Postgrad Med J       Date:  1973-08       Impact factor: 2.401

  9 in total
  101 in total

1.  Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.

Authors:  Paul W H I Parren; Tom W Geisbert; Toshiaki Maruyama; Peter B Jahrling; Dennis R Burton
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Evaluation of perceived threat differences posed by filovirus variants.

Authors:  Jens H Kuhn; Lori E Dodd; Victoria Wahl-Jensen; Sheli R Radoshitzky; Sina Bavari; Peter B Jahrling
Journal:  Biosecur Bioterror       Date:  2011-11-09

3.  Surge capacity for response to bioterrorism in hospital clinical microbiology laboratories.

Authors:  Daniel S Shapiro
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Negative-pressure plastic isolator for patients with dangerous infections.

Authors:  P C Trexler; R T Emond; B Evans
Journal:  Br Med J       Date:  1977-08-27

5.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 6.  Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Authors:  Tjeerd G Kimman; Eric Smit; Michèl R Klein
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 7.  Emerging targets and novel approaches to Ebola virus prophylaxis and treatment.

Authors:  Jin Huk Choi; Maria A Croyle
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

8.  Discovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013-2016.

Authors:  Joel G Breman; David L Heymann; Graham Lloyd; Joseph B McCormick; Malonga Miatudila; Frederick A Murphy; Jean-Jacques Muyembé-Tamfun; Peter Piot; Jean-François Ruppol; Pierre Sureau; Guido van der Groen; Karl M Johnson
Journal:  J Infect Dis       Date:  2016-06-29       Impact factor: 5.226

Review 9.  Epidemiology and Management of the 2013-16 West African Ebola Outbreak.

Authors:  M L Boisen; J N Hartnett; A Goba; M A Vandi; D S Grant; J S Schieffelin; R F Garry; L M Branco
Journal:  Annu Rev Virol       Date:  2016-08-15       Impact factor: 10.431

10.  Lassa fever, Marburg and Ebola virus diseases and other exotic diseases: is there a risk to Canada?

Authors:  A J Clayton
Journal:  Can Med Assoc J       Date:  1979-01-20       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.